Hennes, Aurélie
Devroe, Johanna
De Clercq, Katrien
Ciprietti, Martina
Held, Katharina
Luyten, Katrien
Van Ranst, Nele
Maenhoudt, Nina
Peeraer, Karen
Vankelecom, Hugo
Voets, Thomas
Vriens, Joris
Funding for this research was provided by:
Research Council of the KU Leuven (C14/18/106, C14/18/106, C14/18/106, C14/18/106)
Fonds Wetenschappelijk Onderzoek (G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N, G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N, G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N, G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N, G.0D1417N, G.084515N, G.0A6719N, 12R4622N, 12U7918N)
Article History
Received: 2 January 2023
Accepted: 23 March 2023
First Online: 15 April 2023
Declarations
:
: All animal experiments were reviewed and approved by the Ethical Committee for Animal Experiments of KU Leuven, Belgium (P102/2017). Human endometrial organoids (hEMO) were generated from endometrial biopsies obtained from hormonally non-treated patients undergoing laparoscopy for benign gynecological conditions, with approval of the Ethical Committee of the UZ/KU Leuven (S59006), after written informed consent of the patient. Human blastocysts were collected at the Leuven University Fertility Centre with approval of the Ethical Committee of the UZ/KU Leuven (S62765) and the federal Commission for medical and scientific research on embryo’s in vitro, after written informed consent of the patient.
: Not applicable.
: The authors declare no competing interests.